Hospital
Salem County Hospital Corp.
Salem County Hospital Corp. was paid $13.73M by Medicaid between Feb 2019 and Sep 2023, across 161 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoSALEM COUNTY HOSPITAL CORP.
SALEM, NJ 08079
SALEM, NJ 08079
33aNPI1700351947assigned 10/03/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.73M
24GClaims293,202
24DCodes billed161
24AFirst – last monthFeb 2019 – Sep 2023
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#58 of 93
Median peer was paid$30.60M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 52,151 | $2.53M | |
| 2020 | 43,356 | $1.93M | |
| 2021 | 63,811 | $3.19M | |
| 2022 | 76,807 | $3.55M | |
| 2023 | 57,077 | $2.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 17,053 | 15,519 | $4.95M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 10,171 | 9,105 | $2.78M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.5% | 5,628 | 5,002 | $1.30M |
| G0378 | Hospital observation service, per hour | 3.5% | 1,299 | 1,116 | $486K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.8% | 1,599 | 1,516 | $385K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.4% | 2,906 | 2,778 | $325K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 2,806 | 2,684 | $323K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 8,098 | 6,959 | $300K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 8,700 | 7,455 | $176K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 3,234 | 2,973 | $166K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 11,193 | 2,759 | $158K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 3,712 | 3,268 | $154K |
149 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 5,905 | $153K |
| OP370 | <1% | 1,692 | $133K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 172 | $131K |
| 97010 | <1% | 3,120 | $109K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,406 | $98K |
| OP250 | <1% | 47,225 | $96K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 638 | $78K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 7,824 | $75K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,788 | $73K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,484 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,035 | $61K |
| OP710 | <1% | 1,694 | $59K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 157 | $56K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,401 | $49K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 852 | $49K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12,534 | $49K |
| 73564 | <1% | 1,148 | $44K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,157 | $44K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 876 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,246 | $31K |
| 73630 | <1% | 1,356 | $28K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,289 | $27K |
| 73030 | <1% | 1,071 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 340 | $26K |
| 97161 | <1% | 757 | $24K | |
| 72110 | <1% | 442 | $24K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 852 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 393 | $23K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 190 | $22K |
| 73130 | <1% | 1,129 | $22K | |
| 96376 | <1% | 694 | $21K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 205 | $21K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 734 | $19K |
| 76770 | <1% | 195 | $19K | |
| 84484 | <1% | 4,323 | $17K | |
| 73610 | <1% | 961 | $17K | |
| 97162 | <1% | 359 | $15K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,497 | $14K |
| 76830 | Ultrasound, transvaginal | <1% | 168 | $13K |
| 81001 | <1% | 8,536 | $11K | |
| 73110 | <1% | 633 | $11K | |
| 93971 | <1% | 85 | $11K | |
| 82962 | <1% | 4,247 | $11K | |
| 82553 | <1% | 3,699 | $11K | |
| 76801 | <1% | 120 | $10K | |
| 83880 | <1% | 1,157 | $10K | |
| 72100 | <1% | 326 | $10K | |
| 0012A | <1% | 400 | $10K | |
| 82550 | <1% | 3,893 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 940 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,545 | $9K |
| 0011A | <1% | 397 | $9K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 155 | $9K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,689 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,053 | $8K |
| 84703 | <1% | 5,625 | $8K | |
| 80076 | <1% | 3,262 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,045 | $8K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 15 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 939 | $7K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,629 | $7K |
| 83735 | <1% | 2,711 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 587 | $6K |
| 83690 | <1% | 3,238 | $6K | |
| OP621 | <1% | 2,047 | $6K | |
| 73502 | <1% | 241 | $6K | |
| OP272 | <1% | 386 | $5K | |
| 86850 | <1% | 689 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 43 | $5K |
| 85610 | <1% | 1,636 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 310 | $5K |
| 85027 | <1% | 794 | $5K | |
| 73562 | <1% | 323 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,492 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 715 | $4K |
| 83605 | <1% | 471 | $4K | |
| 86900 | <1% | 736 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,064 | $3K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 117 | $3K |
| 85730 | <1% | 961 | $2K | |
| 86901 | <1% | 735 | $2K | |
| 87081 | <1% | 587 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $2K |
| 82248 | <1% | 398 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 140 | $2K |
| 85379 | <1% | 859 | $2K | |
| 0071A | <1% | 43 | $2K | |
| 97014 | <1% | 133 | $2K | |
| 90715 | <1% | 414 | $2K | |
| 87040 | <1% | 245 | $1K | |
| 80061 | Lipid panel | <1% | 289 | $1K |
| 0072A | <1% | 34 | $1K | |
| 0002A | <1% | 35 | $1K | |
| 0001A | <1% | 30 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 133 | $1K |
| 70486 | <1% | 28 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 37 | $916.20 |
| 74018 | <1% | 50 | $855.30 | |
| 87186 | <1% | 204 | $795.24 | |
| 97116 | <1% | 47 | $773.94 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 790 | $760.80 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 189 | $626.80 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 40 | $598.34 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 51 | $503.37 |
| 77080 | <1% | 12 | $464.67 | |
| 0013A | <1% | 19 | $455.48 | |
| 72050 | <1% | 12 | $428.65 | |
| 84702 | <1% | 92 | $399.43 | |
| 73080 | <1% | 27 | $367.27 | |
| 84100 | <1% | 438 | $365.00 | |
| 72070 | <1% | 15 | $364.67 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,040 | $364.01 |
| 71250 | <1% | 15 | $358.23 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 250 | $321.70 |
| 81003 | <1% | 65 | $294.11 | |
| 87077 | <1% | 54 | $267.83 | |
| 74022 | <1% | 14 | $264.89 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 16 | $238.61 |
| 82803 | <1% | 99 | $236.94 | |
| OP255 | <1% | 33 | $203.37 | |
| 87088 | <1% | 141 | $174.78 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,859 | $158.09 |
| 88342 | <1% | 26 | $146.48 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 768 | $134.60 |
| J2704 | Injection, propofol, 10 mg | <1% | 958 | $115.25 |
| 87420 | <1% | 63 | $114.73 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 839 | $110.09 |
| 82728 | <1% | 14 | $94.45 | |
| 12011 | <1% | 12 | $68.61 | |
| 91301 | <1% | 736 | $65.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 822 | $48.74 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 429 | $26.99 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 640 | $25.02 |
| 83540 | <1% | 13 | $22.36 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 277 | $14.03 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 368 | $12.47 |
| 86140 | <1% | 13 | $12.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 95 | $8.86 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 97 | $7.57 |
| 85652 | <1% | 14 | $7.50 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 155 | $7.44 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 27 | $5.58 |
| 91300 | <1% | 101 | $3.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 13 | $2.73 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 14 | $2.00 |
| OP258 | <1% | 13 | $1.22 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 212 | $1.00 |
| 91307 | 0% | 88 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLGAN, WILLIAM (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Salem Asc LLC | Salem, NJ | $1.86M |
| Salem Physician Practices, P.C. | Salem, NJ | $728K |
| Salem Home Health, LLC | Salem, NJ | $367.50 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.